Researchers at the University of South Australia have ascertained that millions of older people with poor vision are at risk of being misdiagnosed with mild cognitive impairments.
Read More
Turning our attention to age-related macular degeneration – Specsavers
As part of Macula Month, DR JOSEPH PAUL, head of professional services at Specsavers, reveals data and insights on macular degeneration and discusses the organisation’s long-term plans to improve vision and health outcomes for patients with the condition.
Read More
Read More
Smoking and alcohol linked to increased risk of AMD
Are smoking, alcohol intake, blood pressure, body mass index, and glycemic traits associated with age-related macular degeneration (AMD)?
Read More
Read More
AI-driven headset that detects AMD set for Australian debut
A US company that has incorporated dark adaptometry into a new wearable headset for age-related macular degeneration (AMD) is on the cusp of introducing the AI-guided technology to the Australian ophthalmic market.
Read More
Read More
Study: AMD patients at higher risk of COVID-19 death
A new study has found that people with age-related macular degeneration (AMD) are at greater risk of developing severe complications and dying from COVID-19.
Read More
Read More
Tackling treatment adherence in AMD
As part of Macula Month this May, Insight explores why treatment adherence remains such a major challenge for some patients and how the sector is working to overcome it.
Read More
Read More
Protein in blood a direct link to AMD
Scientists have identified a new protein that could help establish improved diagnosis and treatment of age-related macular degeneration (AMD).
Read More
Read More
Novartis AMD drug Beovu secures European approval
European drug regulators have followed in the footsteps of their Australian and US counterparts, following the approval of Novartis’ new anti-VEGF therapy.
Read More
Read More
Gene responsible for ageing of eye found
In a discovery that could have significant implications for how age-related ocular diseases are diagnosed and treated, researchers have pinpointed a specific gene linked to the effect ageing has on the eye.
Read More
Read More
Study highlights biomarker for discontinuing anti-VEGF treatment
A new study has demonstrated that a particular biomarker can be used to select which age-related macular degeneration (AMD) patients can discontinue their anti-VEGF therapy.
Read More
Read More